Program—Wednesday, July 26

Plenaries

  • PL3.1 STIs in Criminalised Populations – Frances Cowan
  • PL3.2 Refugee and Migrant Care – Valeska Padovese

ASTDA: Young Investigator – Plenary Session

  • YI1 A large-scale drug screen identifies novel therapeutics that target the syphilis pathogen Treponema pallidum – Kathryn Hayes
  • YI2 Feedbacks from HIV self-test users in Brazil: monitoring strategy and results – Adson da Paixão
  • YI3 Predicting the Potential Impact of a Novel Chlamydia Vaccine in the United States – Monia Makhoul
  • YI4 Effect of antenatal Chlamydia trachomatis and Neisseria gonorrhoeae screening on post-delivery prevalence and vertical transmission in Gaborone, Botswana – Aamirah Mussa
  • YI5 Sexually Transmitted Infections Among Youth Exposed to Violence & Mental Health Outcomes in Zimbabwe – Edson Chipalo
  • YI6 Effect of antibiotic treatment on commensal Neisseria species load and presence in the oropharynx. – Sem Vellema
  • YI7 Development of a novel human oral tissue model of gonorrhoea – Tamara Matthyssen

Spotlight: Epidemic Preparedness, mpox and beyond

Organizer: Andy Winter
Moderators: Andy Winter and Kyle Bernstein

  • SP3.1 Mpox – state of the art clinical review – Boghuma Titanji
  • SP3.2 Strengthening epidemic preparedness – Nicola Low
  • SP3.3 Personal reflections on mpox and stigma – Harun Tulunay

Spotlight: Addressing the HIV and STI syndemic: what prevention looks like in 2023

Organizer: Meredith Clement
Moderators: Meredith Clement and Matthew Golden

  • SP4.1 Improving the HIV PEP / PrEP interface – Sheena McCormack
  • SP4.2 STI biomedical prevention in 2023: DoxyPEP and beyond – Connie Celum
  • SP4.3 Integrating HIV and STI research: Breaking down the silos – Hyman Scott

Symposium: Novel strategies to optimize vaginal health - Christina Muzny & Erica Plummer

Organizer: Christina Muzny and
Moderators: Christina Muzny and Erica Plummer

  • SY5.1 Menstrual Cups: A Potential Intervention for Preventing BV – Supriya Mehta
  • SY5.2 Male partner treatment for Women with Bacterial Vaginosis – Catriona Bradshaw
  • SY5.3 Vaginal microbiota transplant to promote Lactobacillus-dominant cervico-vaginal microbial communities – Caroline Mitchell
  • SY65.4 Advances in BV Biofilm Research and Investigational Treatments in this Area – Nuno Cerca

Symposium: Centering Equity, Inclusion and Diversity in STI/HIV Research

Organizer: Lizzi Torrone
Moderators: Jagadīśa-devaśrī Dācus and Lizzi Torrone

  • SY6.1 Why is it critical to center equity, inclusion, diversity in STI/HIV research? – Margaret Kisikaw Piyesis
  • SY6.2 What are possible unintended consequences of research? – Emily Learner
  • SY6.3 Evidence based approaches to center equity, inclusion, and diversity – Zinhle Sokhela
  • SY6.4 Building trust in communities for STI prevention interventions – Roxanne Keran

Symposium: Neglected and Emerging STIs

Organizer: Remco Peters
Moderators: Remco Peters and Pingyu Zhou

  • SY7.1 Disseminated gonorrhoea – often overlooked – Amy Jennison
  • SY7.2 Has chancroid been eliminated in Africa? Tania Crucitti
  • SY7.3 Emerging causes of urethritis – Erica Plummer
  • SY7.4 Understanding shigellosis in men who have sex with men – Gwenda Hughes

Symposium: Implementation to Scale

Organizer: Sebastian Fuller
Moderators: Jeanne Marrazzo and Patty Kissinger

  • SY8.1 What can implementation science tell us about sustaining and scaling-up innovations? – Sebastian Fuller
  • SY8.2 Should every successful intervention be scaled-up? The SHE clinic: an inclusive, locally-specific healthcare model for women who use drugs and exchange sex in Seattle, WA – Maria Corcorran
  • SY8.3 Policy and clinical readiness analysis: barriers and facilitators to the integration of doxycycline post-exposure prophylaxis into Kenyan HIV PrEP programs – Felix Ong’era Mogaka
  • SY8.4 Trickle-up HIV care – Jade Pagkas-Bather

Oral Session: Improving management of gonorrhea in times of increasing antimicrobial resistance

Moderators: Hunter Handsfeld and Kathy Hsu

  • O7.1 Within-person differences of N. gonorrhoeae antimicrobial resistance patterns between anatomical locations – Maartje Visser
  • O7.2 Routine Pharyngeal Gonorrhea Test-of-Cure: Does It Detect Treatment Failures? – Laura Quilter
  • O7.3 The impact of near-to-patient testing of sexually transmitted infections on clinical practice and antimicrobial stewardship: the NEPTUNE study – Lenka Vodstrcil
  • O7.4 Neisseria gonorrhoeae diagnostic escape from a gyrA-based test for ciprofloxacin susceptibility and the impact on zoliflodacin resistance – Daniel Rubin
  • O7.5 Perceived benefits and implementation considerations for a novel lateral flow assay for the point-of-care detection of Neisseria gonorrhoeae in public healthcare facilities in South Africa – Lindsey de Vos
  • O7.6 Resistance-minimizing strategies for introducing a novel antibiotic for gonorrhea treatment: a mathematical modeling study – Yonatan Grad

Oral Session: The Future of STI Detection and Treatment: AI, Bots, and More!

Moderators: Preethi Pathela and Yudara Kularathne

  • O8.1 Chatbot-Assisted Self-Assessment (CASA): Designing a novel AI-enabled sexual health intervention for racially minoritised communities – Tom Nadarzynski
  • O8.2 Artificial intelligence-assisted diagnostic tool for early detection of sexually transmitted infections –Nyi Nyi Soe
  • O8.3 Adapting an Artificial Intelligence Sexually Transmitted Infections Screening Tool for Monkeypox Detection: The HeHealth Experience – Yudara Kularathne
  • O8.4 Health Information Exchange Enables Enhanced STI Surveillance Using Electronic Health Record Data – Harry Reyes Nieva
  • O8.5 Validation of an Easy to Administer Algorithm to Define Penicillin Allergy Status in STI Clinic Outpatients – Rebecca Lillis
  • O8.6 InSignia®: A molecular viability test for Chlamydia trachomatis and Neisseria gonorrhoeae – Nicole Lima

Oral Session: It’s worth a shot: the Science of stopping a global syphilis epidemic, one genome at a time

Moderator: Khalil Ghanem and Marco Cusini

  • O9.1 The clinical and genomic diversity of Treponema pallidum among early syphilis patients enrolled in a global consortium for syphilis vaccine development – Arlene Seña
  • O9.2 Treponema pallidum Proteomic Analysis to Inform Syphilis Vaccine Development – Simon Houston
  • O9.3 Syphilis and the Host; multi-omic analysis of host cellular responses to Treponema pallidum provides novel insight into syphilis pathogenesis – Sean Waugh
  • O9.4 Syphilis vaccine development: Generating a stable and efficacious multi-epitope vaccine chimera through protein engineering – Alloysius Gomez
  • O9.5 Persons with Early Syphilis Make Antibodies that Differentially Recognize Extracellular Loops of Treponema pallidum Outer Membrane Proteins – M. Anthony Moody

Oral Session: STIs: a global health crisis, but not a lost cause

Moderators: Joe Tucker and Jorge Saavedra

  • O10.1 What is the true global burden of sexually transmitted infections? What is and is not included in the Global Burden of Disease estimates – Nicola Low
  • O10.2 STI epidemiology in the time of COVID-19 pandemic in European Union/European Economic Area (EU/EEA) countries– data artifact or real impact of the pandemic? – Otilia Mårdh
  • O10.3 Gini coefficients for measuring the disparity in the distribution of HIV and sexually transmitted infections in both heterosexual and homosexual populations in Australia – Lei Zhang
  • O10.4 Using a candidacy framework to investigate barriers and facilitators of a tailored HIV prevention and community based sexual and reproductive health intervention rural South Africa – Manono Luthuli 
  • O10.5 Sexual and reproductive health among migrant peoples in transit through Darién, Panama: results from a rapid epidemiological study – Jennifer Toller Erausquin 
  • O10.6 Health Systems Response for Sexual and Reproductive Health Services During COVID-19: A Systematic Review and Global Crowdsourcing Open Call – Eneyi E Kpokiri

Oral Session: Gonorrhoea: epidemiology and vaccine

Moderators: Jo-Anne Dillon and Maria Luiza Bazzo

  • O11.1 Optimal gonorrhea control through vaccination and screening: a mathematical modeling and cost-effectiveness study  – Austin Williams 
  • O11.2 Global Surveillance for Antimicrobial Resistant Neisseria gonorrhoeae through the Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP), 2015-2022 – Rebekah Frankson
  • O11.3 Should we use the 4CMenB (Bexsero®) meningitis vaccine to protect men who have sex with men (MSM) in England against gonorrhoea? A model-based analysis of impact and cost-effectiveness. – Dariya Nikitin 
  • O11.4 Characterisation of meningococcal vaccine-induced antibodies to Neisseria gonorrhoeae – Kate Seib
  • O11.5 Targeted metagenomic analysis shows distinct Neisseria gonorrhoeae strains at separate anatomical sites occur more commonly than mixed strain infections: implications for surveillance – Brian van der veer
  • O11.6 Effect of oropharyngeal colonization with Neisseria meningitidis on subsequent risk of gonorrhea – Abigail Norris Turner

Oral Session: Reducing stigma and improving care for sexual minorities and other vulnerable populations

Moderators: Lei Zhang and Beth Meyerson

  • O12.1 Inclusion that matters – Trans and gender diverse peoples’ perspectives on sexual health services in the United Kingdom – Tom Witney
  • O12.2 Measuring and Reducing Enacted Healthcare Stigma for Sexual Minorities and People Living with HIV: An Incognito Patient Approach – M. Kumi Smith
  • O12.3 TXTXT Implementation Preparation: Identifying Contextual Barriers and Facilitators to HIV Medication Adherence Among Youth Across 12 Clinics Nationwide – Katie Nikolajuk
  • O12.4 STI testing and treatment in pregnancy may be limited by re-infection from untreated partners – Mandisa Mdingi
  • O12.5 Mixed methods analysis of network structures, support exchanged, and communication patterns within the social networks of transgender women in Lima, Peru – Cherie S Blair
  • O12.6 Geosocial-Networking App Use Among Men Who Have Sex with Men in High HIV Community Viral Load Areas of Baltimore City – Errol Fields

Late Breaker Oral Session: Gonorrhoea and M. genitalium

Moderators: Christine Khosropour and Yonatan Grad

  • LB2.1 Evolving antimicrobial resistance in Mycoplasma genitalium: an updated global systematic review and meta-analysis – Teck-Phui Chua
  • LB2.2 Does screening for Neisseria gonorrhoeae and Chlamydia trachomatis affect the incidence of these infections in MSM taking HIV-PrEP? Results from a randomized, multicenter, controlled trial – Thibaut Vanbaelen
  • LB2.3 High prevalence of STIs among men engaged in transactional sex and alcohol use in western Kenya: Important implications for STI intervention – Sue Napierala
  • LB2.4 Initial findings from increased gonorrhea culture surveillance in Massachusetts – Heather Elder
  • LB2.5 Detection of two ceftriaxone non-susceptible Neisseria gonorrhoeae isolates in an HIV pre-exposure prophylaxis program in Vietnam – Paul Adamson
  • LB2.6 Development of a Cas13a-based Point-of-Care Test for Neisseria gonorrhoeae Detection and Gyrase A Genotype Determination – Lao-Tzu Allan-Blitz

Gala Dinner River Cruise - SOLD OUT

Your Join us on Wednesday evening of the conference for the Chicago Odyssey Fireworks Dinner Cruise! Enjoy dining and dancing with fellow conference attendees as we sail the scenic Chicago River onto Lake Michigan on a private charter. Limited seating is available so reserve your place now.

$95 for Conference Attendees and $155 for Non-registered Guests

Tickets will be given to those registered at registration. We will be boarding at dockside at the hotel and dress is business casual. The boat will depart the hotel at 7 PM.